Updated Results of a Multicenter Phase I/IB Study of Umbralisib (TGR-1202) in Combination with Ibrutinib in Patients with Relapsed or Refractory MCL or CLL

Drug Category:
Conference Category:
Lead Author: Davids M, et al.
Published Date: 14/06/2017
Download Link: /wp-content/uploads/2019/03/Final%201202%20Ibrutinib%20ICML%20Davids.pdf
Download Text: Download
Popup Confirmation?:
site-sidebar-layout: default
ast-site-content-layout: default
site-content-style: default
site-sidebar-style: default
theme-transparent-header-meta: default
stick-header-meta: default
astra-migrate-meta-layouts: set
Scroll to Top